NASDAQ:MGCD (MGCD) (MGCD) Stock Price, News & Analysis → CBOE shift unlocks new weekend income strategy (From DTI) (Ad) Free MGCD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.03▼$11.0350-Day Range N/A52-Week Range$6.24▼$11.20VolumeN/AAverage Volume15,965 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MGCD) alerts: Email Address Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here About (MGCD)MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.Read More Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… MGCD Stock News HeadlinesJanuary 9, 2024 | msn.comSonu Sood’s ‘Fateh’ is a cinematic tribute to cybercrime victimsDecember 31, 2023 | msn.comLakers' LeBron James irate after foot on line discounts potential tying shot in loss to TimberwolvesMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…November 6, 2023 | msn.com‘Defuse it quickly;’ Police arrest Springfield student who brought gun to football gameApril 5, 2023 | reuters.comSpencer Torkelson knocks in three as Tigers beat AstrosFebruary 11, 2023 | msn.comBusy Wednesday schedule kept Jenna Ortega from returning to You Season 4December 29, 2022 | msn.comWrexham science discovery centre to launch Monday warm hub drop in sessionsDecember 17, 2022 | msn.comF1 News: 2023 Aston Martin AMR23 Reveal Date AnnouncedMarch 28, 2024 | Behind the Markets (Ad)The AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.October 25, 2022 | msn.comThe Northern Belle train returns to Grantham for rare appearance this ChristmasSeptember 28, 2022 | msn.comOpen Thread: Buffalo Sabres vs. Columbus Blue Jackets (Preseason)August 18, 2022 | msn.comL.A. County authorities search for woman, 23, missing since JulySee More Headlines Receive MGCD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MGCD) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/07/2016Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:MGCD Previous SymbolNASDAQ:ANGN CUSIPN/A CIK815093 Webmgcdiagnostics.com Phone+1-651-4844874FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesGreg GreenbergChairman of the BoardMatthew S. Margolies (Age 50)President Todd M. Austin (Age 54)Chief Executive Officer Larry Robert Degen (Age 62)Interim Chief Financial Officer, Chief Accounting Officer, Secretary Hendrik Struik (Age 49)Independent Director MGCD Stock Analysis - Frequently Asked Questions How were (MGCD)'s earnings last quarter? (MGCD) (NASDAQ:MGCD) released its earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analysts' expectations of $9.20 million. What other stocks do shareholders of (MGCD) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG) and Achaogen (AKAO). This page (NASDAQ:MGCD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MGCD) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.